financetom
Business
financetom
/
Business
/
TransDigm withdraws from planned $960 million Stellant Systems acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TransDigm withdraws from planned $960 million Stellant Systems acquisition
Jul 13, 2026 4:53 AM

July 13 (Reuters) - Aeroplane parts maker TransDigm ( TDG )

said on Monday it was withdrawing from its proposed $960 million

acquisition of Stellant Systems, a portfolio company of

Arlington Capital Partners.

The company recently concluded that pursuing the transaction

through the regulatory review process was no longer in its best

interest, TransDigm ( TDG ) said in a regulatory filing.

* The Cleveland, Ohio-based manufacturer said it "remains

committed to its disciplined acquisition strategy and continues

to evaluate acquisition opportunities that it believes will

enhance long-term shareholder value."

* The company raised its annual profit forecast in May after

posting a better-than-expected quarterly profit on strong

aftermarket demand.

* TransDigm ( TDG ) develops, manufactures and delivers specialized

aircraft components used in almost every commercial and military

aircraft in service.

* Defense tech co Stellant designs and makes high-power

radio frequency and microwave amplification systems used in

military, space, communications, medical and industrial

applications.

(Reporting by Megavarshini G. Somasundaram in Bengaluru;

Editing by Joyjeet Das)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Polyrizon Says Nasarix Allergy Nasal Spray Meets All Biocompatibility Safety Standards in Testing
Polyrizon Says Nasarix Allergy Nasal Spray Meets All Biocompatibility Safety Standards in Testing
Jul 2, 2026
09:06 AM EDT, 07/02/2026 (MT Newswires) -- Polyrizon ( PLRZ ) said Thursday that its proprietary Nasarix nasal spray met all required biological safety standards in a biocompatibility evaluation program. The testing followed internationally recognized standards and all key endpoints, including cytotoxicity, sensitization, irritation, and systemic toxicity, met acceptance criteria, the company said. The completion of the program is an...
NATO plans to replace AWACS with Saab GlobalEye jets, sources say
NATO plans to replace AWACS with Saab GlobalEye jets, sources say
Jul 2, 2026
BERLIN/PARIS, July 2 (Reuters) - NATO plans to replace its ageing fleet of AWACS aircraft with GlobalEye surveillance planes from Sweden's Saab, four sources familiar with the matter told Reuters, a move that could test uneasy relations with U.S. President Donald Trump. Trump has been pushing allies to purchase American weapons and has repeatedly threatened to quit NATO, accusing European...
Tesla posts record second-quarter deliveries as Europe sales rebound
Tesla posts record second-quarter deliveries as Europe sales rebound
Jul 2, 2026
July 2 (Reuters) - Tesla posted record second-quarter deliveries on Thursday that beat Wall Street estimates, as a demand rebound in Europe more than offset continued weakness in North America. The stronger-than-expected deliveries suggest Tesla's core vehicle business is regaining momentum after two years of decline, easing concerns about the segment that still generates most of the company's revenue. Investors...
Jabil Files Automatic Mixed Shelf Registration
Jabil Files Automatic Mixed Shelf Registration
Jul 2, 2026
09:12 AM EDT, 07/02/2026 (MT Newswires) -- Jabil ( JBL ) filed an automatic shelf registration statement Thursday for the sale of securities from time to time. The securities covered include common stock, preferred stock, debt securities, warrants, depositary shares, and units. Proceeds from any sale of securities under the registration statement will be used for general corporate purposes, including...
Copyright 2023-2026 - www.financetom.com All Rights Reserved